John Stuelpnagel
Vermögen: 40 Mio $ am 31.12.2025
Profil
John R. Stuelpnagel ist ein Unternehmer und Geschäftsmann, der Illumina, Inc., Fabric Genomics, Inc. und Ariosa Diagnostics, Inc. gegründet hat und der an der Spitze von 6 verschiedenen Unternehmen stand. Er ist Vorsitzender bei 10X Genomics, Inc. und bei Fabric Genomics, Inc. sowie Vorsitzender bei Inscripta, Inc. und Element Biosciences, Inc. John R. Stuelpnagel ist außerdem Mitglied des Vorstands von Federation Bio, Inc. und Encoded Therapeutics, Inc. In der Vergangenheit hatte Dr. Stuelpnagel die Position des Chief Operating Officer & Director bei Illumina, Inc. inne, war Associate bei CW Group, Inc. und BRD bei Sequenta, Inc. und Executive Chairman von Ariosa Diagnostics, Inc. Er erwarb einen Doktortitel und einen Bachelor-Abschluss an der University of California, Davis und einen MBA an der University of California, Los Angeles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
10X GENOMICS INC 10,47 % | 31.03.2025 | 2.105.736 ( 10,47 % ) | 34 Mio $ | 31.12.2025 |
10X GENOMICS INC CLASS A 0,31 % | 03.06.2025 | 359.607 ( 0,31 % ) | 6 Mio $ | 31.12.2025 |
Aktuelle Nachrichten zu John Stuelpnagel
Aktive Positionen von John Stuelpnagel
| Unternehmen | Position | Beginn |
|---|---|---|
| 10X GENOMICS, INC. | Vorsitzender | 01.08.2013 |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Gründer | - |
Inscripta, Inc.
Inscripta, Inc. Develops biomanufacturing solutions | Vorsitzender | 01.04.2017 |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 01.05.2017 |
Federation Bio, Inc.
Federation Bio, Inc. Research and develops micro biome therapeutics | Direktor/Vorstandsmitglied | 01.06.2020 |
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Berater | 01.01.1998 |
Ehemalige bekannte Positionen von John Stuelpnagel
| Unternehmen | Position | Ende |
|---|---|---|
Element Biosciences, Inc.
Element Biosciences, Inc. Develops DNA sequencing technology for the research and diagnostic markets | Vorsitzender | 01.01.2023 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Direktor/Vorstandsmitglied | 01.11.2017 |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Offers diagnostics and genetic testing services | Gründer | 01.01.2015 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Stuelpnagel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Sequenta, Inc.
Sequenta, Inc. Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | |
10X Genomics, Inc.
10X Genomics, Inc. Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Offers diagnostics and genetic testing services | |
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. Develops sequencing assays for the adaptive immune system | |
Inscripta, Inc.
Inscripta, Inc. Develops biomanufacturing solutions | |
Federation Bio, Inc.
Federation Bio, Inc. Research and develops micro biome therapeutics | |
Element Biosciences, Inc.
Element Biosciences, Inc. Develops DNA sequencing technology for the research and diagnostic markets | |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. |
















